Objectivity Squared’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Hold
10,915
0.01% 56
2026
Q1
$19.9K Hold
10,915
0.01% 55
2025
Q4
$21.1K Buy
+10,915
New +$21.8K 0.01% 57
2024
Q2
Sell
-2,250
Closed -$12.9K 49
2024
Q1
$12.9K Buy
2,250
+1,417
+170% +$6.94K 0.01% 47
2023
Q4
$3.09K Buy
+833
New +$3.81K ﹤0.01% 44

Other funds holding DARE

Objectivity Squared's DARE Position: Q2 2026 in Review

Objectivity Squared held its Dare Bioscience (DARE) position steady in Q2 2026 at 10,915 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #56.

Objectivity Squared first reported a position in DARE in Q4 2023 and has held it in 5 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Objectivity Squared held 10,915 shares of Dare Bioscience worth $23K as of Q2 2026.
  • Objectivity Squared left its Dare Bioscience share count unchanged in Q2 2026.
  • Dare Bioscience made up 0.01% of Objectivity Squared's portfolio in Q2 2026, its #56 holding.
  • Objectivity Squared first reported a position in Dare Bioscience in Q4 2023 and has held it in 5 quarters since.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Objectivity Squared's 13F filing for Q2 2026, filed 7 Aug 2026.